Chlorpheniramine maleate; phenylpropanolamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorpheniramine maleate; phenylpropanolamine hydrochloride and what is the scope of patent protection?
Chlorpheniramine maleate; phenylpropanolamine hydrochloride
is the generic ingredient in three branded drugs marketed by Graham Dm and Novartis, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for chlorpheniramine maleate; phenylpropanolamine hydrochloride
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 2 |
NDAs: | 3 |
DailyMed Link: | chlorpheniramine maleate; phenylpropanolamine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for chlorpheniramine maleate; phenylpropanolamine hydrochloride
US Patents and Regulatory Information for chlorpheniramine maleate; phenylpropanolamine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Graham Dm | COLD CAPSULE V | chlorpheniramine maleate; phenylpropanolamine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018794-001 | Apr 23, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | TRIAMINIC-12 | chlorpheniramine maleate; phenylpropanolamine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 018115-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graham Dm | COLD CAPSULE IV | chlorpheniramine maleate; phenylpropanolamine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018793-001 | Apr 25, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |